"The U.S. Food and Drug Administration today approved Orbactiv (oritavancin), a new antibacterial drug to treat adults with skin infections.
Orbactiv is approved to treat patients with acute bacterial skin and skin structure infections (ABSS"...
ULESFIA® Lotion is indicated for the topical treatment of head lice infestation in patients 6 months of age and older.
Limitation Of Use
ULESFIA® Lotion does not have ovocidal activity.
ULESFIA® Lotion should be used in the context of an overall lice management program:
- Wash (in hot water) or dry-clean all recently worn clothing, hats, used bedding, and towels.
- Wash personal care items such as combs, brushes and hair clips in hot water.
- A fine-tooth comb or special nit comb may be used to remove dead lice and nits.
DOSAGE AND ADMINISTRATION
ULESFIA® Lotion is not for oral, ophthalmic, or intravaginal use.
Using the guidelines in Table 1, apply sufficient ULESFIA® Lotion to dry hair to completely saturate the scalp and hair; leave on for 10 minutes, then thoroughly rinse off with water. Repeat application after 7 days. Avoid contact with eyes.
Table 1: ULESFIA® Lotion Usage Guideline
|Hair Length||Amount of ULESFIA® Lotionper Application|
|Ounces||8 oz bottle Size|
|Short||0-2 inches||4-6 oz||½ to ¾ bottle|
|2-4 inches||6-8 oz||¾-1 bottle|
|Medium||4-8 inches||8-12 oz||1-1½ bottles|
|8-16 inches||12-24 oz||1½-3 bottles|
|Long||16-22 inches||24-32 oz||3-4 bottles|
|Over 22 inches||32-48 oz||4-6 bottles|
Dosage Forms And Strengths
ULESFIA® Lotion is a white topical lotion containing benzyl alcohol, 5% (50 mg/g of lotion).
Storage And Handling
ULESFIA® Lotion is a white topical lotion containing benzyl alcohol, 5% (50 mg/g of lotion)
NDC 59212-780-08 as an 8 fl oz (227 g) in a polypropylene
NDC 59212-780-88 as a package containing two individual 8 fl oz (NDC 59212-780-08) polypropylene bottles with a nit comb
Store at 20° C - 25° C (68° F - 77° F); excursions permitted to 15° C - 30° C (59° F - 86° F) [See USP controlled room temperature].
Do not freeze.
MANUFACTURED FOR: Concordia Pharmaceuticals Inc., Bridgetown, Barbados BB11128. BY: Contract Pharmaceuticals Limited, Mississauga, Ontario L5N 6L6, Canada. Revised: 09/2013This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 3/17/2016
Additional Ulesfia Information
Ulesfia - User Reviews
Ulesfia User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.